“Lazarus Response” to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion

This report describes an estrogen receptor-positive breast cancer patient, who relapsed at two and a half years after the completion of adjuvant chemotherapy while being on the aromatase inhibition. Based on the clinical evidence for potential sensitivity of the tumor to hormone ablation, everolimus...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cureus
Egile Nagusiak: Moiseyenko, Vladimir M, Chubenko, Vyacheslav A, Moiseyenko, Fedor V, Zagorskaya, Lyudmila A, Zaytseva, Yuliya A, Gesha, Nataliya E, Zykov, Evgeny N, Ni, Valeriya I, Preobrazhenskaya, Elena V, Sokolenko, Anna P, Imyanitov, Evgeny N
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cureus 2018
Gaiak:
Genetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890964/
https://ncbi.nlm.nih.gov/pubmed/29651367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2150
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak